For the Quarter Ending March 2026
Chlorpheniramine Maleate Prices in North America
- In United States, the Chlorpheniramine Maleate Price Index rose quarter-over-quarter in Q1 2026, driven by elevated input costs.
- The Chlorpheniramine Maleate Production Cost Trend increased in March 2026 as the Producer Price Index rose 4.0%.
- The Chlorpheniramine Maleate Price Forecast reflected upward momentum in March 2026, supported by 3.3% CPI inflation.
- The Chlorpheniramine Maleate Demand Outlook strengthened in March 2026, driven by a 4.0% year-over-year retail sales growth.
- The Manufacturing Index expanded in March 2026, tightening the Chlorpheniramine Maleate Price Index due to robust pharmaceutical activity.
- Industrial production grew 0.7% in March 2026, ensuring steady baseline supply for Chlorpheniramine Maleate without significant overcapacity.
- Seasonal consumer demand for Chlorpheniramine Maleate allergy medications strengthened in March 2026, tightening overall retail availability.
- A stable 4.3% unemployment rate in March 2026 sustained inelastic consumer demand for Chlorpheniramine Maleate allergy treatments.
Why did the price of Chlorpheniramine Maleate change in March 2026 in North America?
- The Producer Price Index rose 4.0% in March 2026, passing elevated production costs to manufacturers.
- Retail availability for combination Chlorpheniramine Maleate decongestant products tightened significantly throughout the Q1 2026 period.
- Maleic anhydride precursor costs surged before stabilizing in March 2026, directly impacting chemical synthesis expenses.
Chlorpheniramine Maleate Prices in APAC
- In China, the Chlorpheniramine Maleate Price Index rose quarter-over-quarter in Q1 2026, driven by surging precursor costs.
- The Chlorpheniramine Maleate Production Cost Trend increased in March 2026 as PPI grew 0.5%, raising factory-gate expenses.
- The Chlorpheniramine Maleate Demand Outlook stabilized in March 2026, supported by a 1.0% CPI increase maintaining purchasing power.
- In March 2026, unemployment reached 5.4% and February 2026 consumer confidence hit 91.6, boosting affordable Chlorpheniramine Maleate demand.
- Sluggish retail sales growth of 1.7% in March 2026 constrained broader consumer spending, impacting overall pharmacy foot traffic.
- Industrial production grew 5.7% and the Manufacturing Index expanded in March 2026, ensuring steady baseline pharmaceutical manufacturing output.
- Butane and benzene precursor costs for Chlorpheniramine Maleate surged in Q1 2026 due to Middle East supply disruptions.
- The Chlorpheniramine Maleate Price Forecast indicated upward pressure in March 2026 as domestic chemical inventories tightened significantly.
Why did the price of Chlorpheniramine Maleate change in March 2026 in APAC?
- Surging butane and benzene precursor costs elevated production expenses for chemical manufacturers throughout Q1 2026.
- Domestic supply of key intermediates tightened in March 2026 due to reduced cracker operating rates.
- Strong API export demand strengthened in Q1 2026, diverting domestic volumes and tightening local availability.
Chlorpheniramine Maleate Prices in Europe
- In Germany, the Chlorpheniramine Maleate Price Index rose quarter-over-quarter in Q1 2026, driven by surging precursor costs.
- The Chlorpheniramine Maleate Production Cost Trend increased in March 2026 as inflation reached 2.7 percent.
- Producer prices declined by -0.2 percent in March 2026, but upstream maleic anhydride feedstock costs strengthened.
- The Manufacturing Index expanded in March 2026, supporting a positive Chlorpheniramine Maleate Demand Outlook for pharmaceuticals.
- Industrial production remained stagnant at 0.0 percent in February 2026, while domestic chemical stockpiles plummeted.
- Retail sales grew 0.7 percent and unemployment stabilized at 4.2 percent in February 2026, sustaining consumption.
- Consumer confidence dropped to -24.7 in March 2026, shifting consumer preference toward generic OTC allergy medications.
- The Chlorpheniramine Maleate Price Forecast remained elevated in Q1 2026 as global chemical tanker freight rates surged.
- Upstream n-butane markets experienced supply worries and price spikes linked to Middle East conflicts in March 2026.
Why did the price of Chlorpheniramine Maleate change in March 2026 in Europe?
- Maleic anhydride feedstock costs strengthened globally in March 2026 due to low regional production loads.
- Global chemical tanker freight rates surged in Q1 2026, complicating intermediate chemical imports into Europe.
- Domestic chemical stockpiles plummeted in January 2026 as producers curtailed operating rates amid market pressures.
For the Quarter Ending December 2025
Chlorpheniramine Maleate Prices in North America
- In the United States, the Chlorpheniramine Maleate Price Index rose quarter-over-quarter in Q4 2025, due to increased production costs and robust demand.
- Chlorpheniramine Maleate production costs increased in Q4 2025, influenced by a 2.7% CPI rise in December 2025 and strengthening natural gas feedstock.
- The Producer Price Index increased 3.0% year-over-year in November 2025, indicating higher input costs for downstream pharmaceutical buyers.
- Chlorpheniramine Maleate demand outlook strengthened in Q4 2025, supported by a 2.0% industrial production increase in December 2025.
- Retail sales rose 3.3% year-over-year in November 2025, reflecting strong consumer spending on OTC medications.
- A 4.4% unemployment rate in December 2025 supported consumer purchasing power, boosting pharmaceutical demand.
- Demand for cold and allergy medications surged in Q4 2025 due to a severe flu season.
- North American chemical producers maintained competitive advantage in 2025, benefiting from low-cost shale gas feedstock.
Why did the price of Chlorpheniramine Maleate change in December 2025 in North America?
- Production costs rose from a 2.7% CPI increase in December 2025 and strengthening natural gas feedstock.
- Robust consumer demand for OTC medications, with retail sales up 3.3% in November 2025, supported prices.
- Industrial production increased 2.0% in December 2025, and a surging flu season boosted demand.
Chlorpheniramine Maleate Prices in APAC
- In China, the Chlorpheniramine Maleate Price Index declined quarter-over-quarter in Q4 2025, influenced by producer price deflation.
- Chlorpheniramine Maleate production costs faced downward pressure in December 2025, as the Producer Price Index fell by 1.9% year-over-year.
- Demand for Chlorpheniramine Maleate was supported by an expanding Manufacturing Index in December 2025, indicating industrial growth.
- Industrial Production increased by 5.2% year-over-year in December 2025, boosting overall demand for pharmaceutical inputs.
- Weak consumer demand, with retail sales growing 0.9% and CPI at 0.8% in December 2025, impacted OTC applications.
- Global overcapacity in chemical building blocks continued to rise in 2025, contributing to ample Chlorpheniramine Maleate inventories.
- China's pharmaceutical and healthcare product exports strengthened in 2025, supporting trade flows for the chemical.
- The unemployment rate of 5.1% in December 2025 contributed to cautious consumer spending, affecting OTC drug demand.
- Regulatory reforms and an intensified anti-corruption campaign in China's healthcare sector influenced market dynamics in 2025.
Why did the price of Chlorpheniramine Maleate change in December 2025 in APAC?
- Producer Price Index declined by 1.9% in December 2025, reducing Chlorpheniramine Maleate production costs.
- Low CPI (0.8%) and weak retail sales (0.9%) in December 2025 dampened consumer demand.
- Global overcapacity in chemical building blocks in 2025 increased inventories and price pressure.
Chlorpheniramine Maleate Prices in Europe
- In Germany, the Chlorpheniramine Maleate Price Index fell in Q4 2025, influenced by decreasing producer prices in December 2025.
- Chlorpheniramine Maleate production costs declined in December 2025, as producer prices decreased by 2.5% year-on-year.
- Demand outlook for Chlorpheniramine Maleate weakened in Q4 2025, with the Manufacturing Index contracting in December 2025.
- Consumer confidence remained significantly pessimistic at -17.5 in December 2025, dampening Chlorpheniramine Maleate demand.
- Retail sales increased by 1.1% year-on-year in November 2025, offering some support for Chlorpheniramine Maleate products.
- Industrial production expanded by 0.8% year-on-year in October 2025, supporting the broader Chlorpheniramine Maleate supply chain.
- Natural gas prices for December 2025 delivery decreased, easing some Chlorpheniramine Maleate production cost pressures.
- Government measures in November 2025 aimed to reduce electricity prices for energy-intensive industries.
Why did the price of Chlorpheniramine Maleate change in December 2025 in Europe?
- Producer prices decreased by 2.5% year-on-year in December 2025, lowering Chlorpheniramine Maleate production costs.
- Consumer confidence at -17.5 in December 2025 significantly weakened demand for related products.
- The Manufacturing Index contracted in December 2025, indicating a slowdown in industrial activity.
For the Quarter Ending September 2025
Chlorpheniramine Maleate Price in North America
- In United States, the Chlorpheniramine Maleate Price Index remained stable quarter-over-quarter in Q3 2025, influenced by global overcapacity.
- Chlorpheniramine Maleate production costs increased in Q3 2025, driven by a 2.6% PPI rise year-over-year in August 2025.
- Natural gas prices strengthened in September 2025, and electricity climbed in August 2025, raising manufacturing expenses.
- US tariffs in Q3 2025 pressured the chemical sector, contributing to Chlorpheniramine Maleate cost increases.
- Consumer demand for Chlorpheniramine Maleate cooled in Q3 2025, despite 5.42% retail sales growth in September 2025.
- A 3.0% CPI increase year-over-year in September 2025 indicated inflation, impacting raw material and labor costs.
- The 4.3% unemployment rate in September 2025 supported purchasing, but consumer confidence declined to 94.2.
- Global overcapacity, particularly from China, kept Chlorpheniramine Maleate chemical margins tight throughout Q3 2025.
Why did the price of Chlorpheniramine Maleate change in September 2025 in North America?
- Production costs rose due to a 2.6% PPI increase in August 2025 and higher energy prices.
- Cooling consumer demand in Q3 2025, despite strong retail sales, limited cost pass-through.
- Global overcapacity, particularly from China, pressured Chlorpheniramine Maleate prices in Q3 2025.
Chlorpheniramine Maleate Price in APAC
- In China, the Chlorpheniramine Maleate Price Index fell quarter-over-quarter in Q3 2025, driven by industrial deflationary pressures.
- Chlorpheniramine Maleate production costs remained elevated in September 2025 due to increased key raw material prices.
- Pharmaceutical demand strengthened from August to September 2025, boosting Chlorpheniramine Maleate consumption.
- China's Manufacturing Index contracted in July and August 2025, signaling reduced API orders.
- The CPI decreased by 0.3% year-on-year in September 2025, indicating weak consumer demand.
- PPI declined by 2.3% year-on-year in September 2025, reflecting falling producer prices.
- Retail sales increased by 3.0% year-on-year in September 2025, supporting end-use product demand.
- Industrial production grew 6.5% in September 2025, while consumer confidence at 89.6 dampened spending.
Why did the price of Chlorpheniramine Maleate change in September 2025 in APAC?
- Deflationary CPI of -0.3% in September 2025 indicated weak consumer demand, pressuring Chlorpheniramine Maleate prices.
- A 2.3% PPI decline in September 2025 reflected falling producer prices and overall weak industrial demand.
- Persistent global chemical overcapacity, especially from China, contributed to downward pressure on Chlorpheniramine Maleate prices.
Chlorpheniramine Maleate Price in Europe
- In Germany, the Chlorpheniramine Maleate Price Index fell quarter-over-quarter in Q3 2025, influenced by subdued demand and decreasing producer input costs.
- Production costs were pressured by elevated raw material and high energy prices throughout Q3 2025.
- Demand for Chlorpheniramine Maleate remained subdued in Q3 2025, despite a modest 0.2% increase in retail sales.
- The Manufacturing Index contracted and industrial production declined 1.0% in September 2025, signaling a weaker economic environment.
- A stable unemployment rate of 6.3% in September 2025 indicated ongoing economic challenges constraining consumer spending.
- Pharmaceutical sector production strengthened in July 2025, offering a positive signal for Chlorpheniramine Maleate demand.
- Global chemical overcapacity persisted, with low capacity utilization in German industry during Q3 2025.
- German chemical exports weakened significantly in Q3 2025, and new tariffs impacted trade with the United States.
Why did the price of Chlorpheniramine Maleate change in September 2025 in Europe?
- Producer Price Index declined 1.7% in September 2025, reducing input costs for German manufacturers.
- Industrial production fell 1.0% in September 2025, contributing to subdued overall chemical demand.
- Consumer Price Index rose 2.4% year-over-year in September 2025, impacting consumer spending.
